早期乳腺癌辅助化疗中文.pptVIP

* USO 9735 是III期临床，研究TC方案的疗效及安全性 目的在于比较非蒽环类方案与标准蒽环类方案治疗可手术乳腺癌 is a phase III study designed to evaluate the efficacy and safety of docetaxel–cyclophosphamide. The goal is to compare a non-anthracycline containing regimen with a standard anthracycline combination for the treatment of patients with operable breast cancer. * * * * * * * * * * * * * Her Neg as of 8 ‘05 * * * * * * NSABP B-38 Disease-Free Survival 0 1 2 3 4 5 0.0 0.2 0.4 0.6 0.8 1.0 Years since Randomization Disease-Free Survival Treat N Events P-value* (vs AC?PG) TAC 1610 327 0.410